Monitoring cardiovascular health in cancer patients
Official title: Cardiovascular Outcome of Cancer Patients: The "GMEDICO Cohort"
Run by Assistance Publique Hopitaux De Marseille · NCT03492528 · Data updated 2026-11-12
This study is testing how cancer treatments affect heart health in cancer patients over five years to find out what factors might lead to heart problems and to create a risk score for better monitoring.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 530 (estimated) |
| Sponsor | Assistance Publique Hopitaux De Marseille Academic / other |
| Drugs / interventions | immunotherapy |
| Locations | 1 site (Marseille) |
| Status | Recruiting |
| Started | July 5, 2019 |
| Main results expected | April 2027 |
| Study ends | October 2027 |
| Registry record updated | September 21, 2022 |
| Trial ID | NCT03492528 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults referred for cardio-oncology consultations prior to starting cancer treatment.
✕Probably not a fit
Patients who are minors, under guardianship, or pregnant/breastfeeding will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
The GMEDICO Cohort aims to assess the cardiovascular prognosis of cancer patients through a collaborative effort between cardiologists and oncologists in France. Patients will be monitored for five years following a standardized protocol that includes clinical evaluations, biological assessments, and imaging studies. The study seeks to identify predictive factors for cardiovascular toxicity associated with cancer treatments and to develop a risk score based on these factors. Additionally, blood samples will be collected for biobanking and further research into biomarkers and genetic factors related to cardiovascular events.
Why it matters
Potential benefit: If successful, this study could lead to improved cardiovascular management and outcomes for cancer patients undergoing treatment.
How similar studies have gone: Other studies have shown success in similar approaches to monitoring cardiovascular health in cancer patients, indicating a promising avenue for further research.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * All adults referred for specialist cardio-oncology consultations before the initiation of a cancer treatment according to pre-established indications will be eligible. Exclusion Criteria: * Failure to provide information that makes it impossible to complete a consultation form or refuse to sign the consent. * Minor or major patient under guardianship * Pregnant or breastfeeding woman
Where it's running
-
Assiatnce Publique Hopitaux de Marseille
Marseille, France Recruiting
Study contacts
- Study coordinator: franck thuny
- Email: franck.thuny@ap-hm.fr
- Phone: 33(0)4 91 96 86 83
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Smartwatch detection of atrial fibrillation after thoracic (lung) surgery
This test sees if a smartwatch's single-lead ECG can find atrial fibrillation early in adults who recently had major thoracic surgery (lobectomy or pneumonectomy).
-
Investigating the impact of a toxin on heart and blood vessel function during acute kidney injury
This study is testing how a harmful toxin that builds up during kidney injury might affect heart and blood vessel function in people with acute kidney injury.
-
Cardiac MRI-based prediction tool for outcomes in dilated cardiomyopathy
This project will test whether adding multi-parameter stress perfusion cardiac MRI to routine clinical data can better predict which people with dilated cardiomyopathy will go on to develop heart failure, arrhythmias, hospitalizations, or death.
-
Long-term outcomes of primary biliary cholangitis in China
This project will follow about 4,000 people in China with primary biliary cholangitis to see how symptoms, disease stage, and treatments affect long-term survival.
-
A kidney cancer prediction model to guide treatment decisions, including for patients with tumor thrombus
This project will test whether a new prediction model can guide treatment choices to improve survival for adults with renal cell carcinoma, including those with venous tumor thrombus.
-
Bone grafting at implant removal to help success of putting a new implant in the same spot
This study tests whether doing bone grafting at the same time as removing a failed dental implant helps people who plan to get a new implant in the same location.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.